A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients "MACH"


Phase 1/2 Results

Summary of Purpose

The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in intracerebral hemorrhage patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 March 2018.

1 Feb 2013 5 Mar 2013 1 Dec 2016 1 Dec 2016 1 Mar 2018 5 Jul 2017
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment